Evidence map›Paper›PMID 29778516›Full record

ArticleVaccine2018

Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center.

Kaan Z Apaydin, Holly B Fontenot, Derri Shtasel, Sannisha K Dale, Christina P C Borba, Christopher S Lathan, Lori Panther, Kenneth H Mayer, Alex S Keuroghlian

Abstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Barriers and Facilitators to HPV Vaccination Completion among Transgender Women in Mexico: Implications for HPV Prevention and Education.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  5. Review
  6. Mapping disparities: identifying cancer care gaps in sexual and gender minority patients.Journal of the National Cancer Institute. Monographs · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kaan Z ApaydinThe Fenway Institute, United States.
Holly B FontenotThe Fenway Institute and Boston College, United States.
Derri ShtaselHarvard Medical School and Massachusetts General Hospital, United States.
Sannisha K DaleUniversity of Miami and Massachusetts General Hospital, United States.
Christina P C BorbaBoston University School of Medicine and Boston Medical Center, United States.
Christopher S LathanDana-Farber Cancer Institute, United States.
Lori PantherThe Fenway Institute, United States.
Kenneth H MayerThe Fenway Institute, Beth Israel Deaconess Medical Center, United States.
Alex S KeuroghlianThe Fenway Institute, Harvard Medical School, and Massachusetts General Hospital, United States. Electronic address: akeuroghlian@partners.org.
Fenway Health · USBoston Medical Center · USDana-Farber Cancer Institute · USHarvard University · USUniversity of Miami · US

Funding

Epidemiological and socio-cultural landscape of schizophrenia in rural EthiopiaK01MH100428 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BORBA, CHRISTINA PAULA CABRAL · 2014 to 2018
$903k
NIMH NIH HHS K01 MH100428
6 · The paper itself

Abstract

backgroundYoung sexual minority individuals have lower human papillomavirus (HPV) vaccine completion rates than the general population, and little is known about how gender minority people perceive HPV vaccination. The aim of this study was to qualitatively identify patient-, provider-, and systems-level barriers and facilitators for HPV vaccination among sexual and gender minority (SGM) people.

methodsFifteen SGM-identified individuals, ages 23-26, were recruited at an urban community health center in Boston, MA, that specializes in care for SGM. Participants were enrolled in a study that utilized surveys and in-person focus groups. During focus groups, participants were asked to describe their perceived barriers and facilitators for completion of HPV vaccination.

resultsFourteen participants reported having a sexual minority identity, and five participants reported having a gender minority identity. Participants described the following factors influencing HPV vaccination: (1) at the patient level, low HPV-related knowledge and lack of engagement in care were associated with less vaccination, whereas fear of HPV-related disease motivated vaccination; (2) at the provider level, knowledge and SGM cultural-competence related to HPV was associated with patient willingness to be vaccinated; (3) at the systems level, SGM identity-affirming healthcare settings were associated with increased vaccination, whereas historical trends in HPV vaccine marketing selectively for cisgender women and lack of public awareness of HPV-related disease among SGM were associated with decreased vaccincation.

conclusionOur study identified internal and external barriers for HPV vaccination related among SGM patients. These findings highlight the need to increase public awareness about the risks of HPV-related disease among SGM and educate SGM youth about HPV-related disease and vaccine importance. Finally, this study supports the need for future interventions to cultivate SGM-competent providers and SGM identity-affirming healthcare settings as a way to increase HPV vaccination.

Indexed as

Sexual and Gender MinoritiesVaccination CoverageAdultBostonCommunity Health CentersFemaleHealth Knowledge, Attitudes, PracticeHumansInterviews as TopicMalePapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareVaccinationYoung AdultPapillomavirus VaccinesHPVHPV-related cancersHuman papillomavirusSexual and gender minorityTransgenderVaccine

Identifiers

PMID29778516
PMCPMC5990434
OpenAlexW2804584939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.